Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy.
- DOI
- 10.1186/s40780-022-00246-x
- Published
- 2022 Jun 1
- Container
- Journal of pharmaceutical health care and sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40780-022-00246-x,
title = {Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy.},
author = {Kondo Y and Tachi T and Sakakibara T and Kato J and Mizuno T and Miyake Y and Teramachi H},
year = {2022},
journal = {Journal of pharmaceutical health care and sciences},
doi = {10.1186/s40780-022-00246-x},
url = {https://doi.org/10.1186/s40780-022-00246-x}
}RIS
TY - JOUR TI - Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy. AU - Kondo Y AU - Tachi T AU - Sakakibara T AU - Kato J AU - Mizuno T AU - Miyake Y AU - Teramachi H PY - 2022 JO - Journal of pharmaceutical health care and sciences DO - 10.1186/s40780-022-00246-x UR - https://doi.org/10.1186/s40780-022-00246-x ER -
APA
Y, K., T, T., T, S., J, K., T, M., Y, M., & H, T. (2022). Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy.. Journal of pharmaceutical health care and sciences. https://doi.org/10.1186/s40780-022-00246-x
Source records
- pubmed · retrieved 2026-09-27T01:35:22.529Z